Tags cancer cells with a synthetic antigen that guides immune therapies to destroy resistant solid tumors with precision and adaptability.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Dispatch Bio is biotechnology company engineering a universal immunotherapy platform that tags solid tumor cells with a synthetic antigen via a viral vector and then directs immune cells to selectively eliminate them. It combines tumor-specific delivery and microenvironment modulation to overcome resistance and enable immunotherapy across multiple solid tumor types .
Dispatch Bio Funding
Sign up to gain insights into Dispatch Bio funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A | Jul 23, 2025 | 114M | ||
| Series Seed | Jul 23, 2025 | 66M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Dispatch Bio Management Team
Investors
Alexandria Venture Investments
University of Pennsylvania
Bristol Myers Squibb
Stanford University
The Parker Institute for Cancer Immunotherapy
ARCH Venture Partners
Dispatch Bio Valuations & Financials
View real-time NPM data on Dispatch Bio stock including daily Dispatch Bio stock price estimates, valuation history, and historical share price information. Access Dispatch Bio financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Dispatch Bio pricing across six independent market signals. Looking for private company due diligence data sources on Dispatch Bio? Get in touch to learn more.
Similar Companies
like Dispatch Bio
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
FAQ
We have answers
Dispatch Bio stock does not trade on public stock exchanges. Dispatch Bio stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Dispatch Bio stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Dispatch Bio Stock does not trade on public stock exchanges. In order to sell Dispatch Bio shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Dispatch Bio does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Dispatch Bio share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Dispatch Bio stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Dispatch Bio stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Dispatch Bio stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Dispatch Bio is a private company and has not had an IPO. There is currently no Dispatch Bio IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Dispatch Bio IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
